title: Severe Rowell syndrome associated with oral terbinafine.
authors.affiliation: Department of Dermatology, Amersham Hospital, Buckinghamshire NHS Trust, Amersham, Buckinghamshire, UK. caroline.champagne@buckshealthcare.nhs.uk
authors.forename: C
authors.initials: C
authors.lastname: Champagne
authors.forename: R
authors.initials: R
authors.lastname: Ratnavel
authors.forename: T
authors.initials: T
authors.lastname: Wong
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004892:Erythema Multiforme / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*; D009281:Naphthalenes / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000175:diagnosis*; D013577:Syndrome; D000077291:Terbinafine
chemical_list: D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine